FH loss can predispose to cancer and has been observed in other tumour types, such as paraganglioma and pheochromocytoma [21–23], adrenocortical carcinoma [24], neuroblastoma [24, 25], glioma, ependymoma, osteosarcoma and Ewing’s sarcoma [24]. This evidence concerns the gene FH and neoplasm.